Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas

Cancer Science

Volumn 98, Issue 7, 2007, Pages 958-963

  Murata, Hiroshi ^a   Ashida, Atsuko ^a   Takata, Minoru ^a   Yamaura, Maki ^a,c   Bastian, Boris C ^b   Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CALCIUM CHLORIDE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; OXYGEN; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CASE REPORT; CELL CYCLE PROGRESSION; CONTROLLED STUDY; CYTOGENETICS; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOCYTE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

AGED; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DNA PRIMERS; HUMANS; MALE; MELANOMA; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 34249885629     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00496.x     Document Type: Article

References (34)

1. Curtin JA, Fridlyand J, Kageshita T et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-47.
2. Landi MT, Bauer J, Pfeiffer RM et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006; 313: 521-2.
3. Curtin JA, Busam K, Pinkel D et al. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340-6.
4. Bastian BC, Kashani-Sabet M, Hamm H et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 2000; 60: 1968-73.
5. Yamaura M, Takata M, Miyazaki A et al. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in.situ. Arch Dermatol 2005; 141: 1413-18.
6. Takata M, Goto Y, Ichii N et al. Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas. J Invest Dermatol 2005; 125: 318-22.
7. Fujimoto A, Morita R, Hatta N et al. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma. Oncogene 1999; 18: 2527-32.
8. Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
9. Bastian BC, LeBoit PE, Hamm H et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998; 58: 2170-5.
10. Halaban R. Growth factors and tyrosine protein kinases in normal and malignant melanocytes. Cancer Metastasis Rev 1991; 10: 129-40.
11. Kawa Y, Ito M, Ono H et al. Stem cell factor and/or endothelin-3 dependent immortal melanoblast and melanocyte populations derived from mouse neural crest cells. Pigment Cell Res 2000; 13 (Suppl 8): 73-80.
12. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992; 267: 24.675-80.
13. Marquardt H, Hunkapiller MW, Hood LE et al. Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: Amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci USA 1983; 80: 4684-8.
14. Rodeck U, Becker D, Herlyn M. Basic fibroblast growth factor in human melanoma. Cancer Cells 1991; 3: 308-11.
15. Johnson SE, Baglioni C. Positive and negative regulation of a tumor necrosis factor response in melanoma cells. J Biol Chem 1990; 265: 6642-9.
16. Shattuck RL, Wood LD, Jaffe GJ et al. MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Mol Cell Biol 1994; 14: 791-802.
17. Elshourbagy NA, Korman DR, Wu HL et al. Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 1993; 268: 3873-9.
18. Yohn JJ, Smith C, Stevens T et al. Human melanoma cells express functional endothelin-1 receptors. Biochem Biophys Res Commun 1994; 201: 449-57.
19. Bittner M, Meltzer P, Chen Y et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000; 406: 536-40.
20. Demunter A, De Wolf-Peeters C, Degreef H et al. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch 2001; 438: 485-91.
21. Lartigau E, Randrianarivelo H, Avril MF et al. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 1997; 7: 400-6.
22. Satyamoorthy K, DeJesus E, Linnenbach AJ et al. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res 1997; 7 (Suppl 2): S35-42.
23. Hsu MY, Meier F, Herlyn M. Melanoma development and progression: A conspiracy between tumor and host. Differentiation 2002; 70: 522-36.
24. Omholt K, Platz A, Kanter L et al. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res 2003; 9: 6483-8.
25. Jiang W, Kahn SM, Tomita N et al. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 1992; 52: 2980-3.
26. Dickson C, Fantl V, Gillett C et al. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett 1995; 90: 43-50.
27. Akervall JA, Michalides RJ, Mineta H et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997; 79: 380-9.
28. Jares P, Fernandez PL, Campo E et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994; 54: 4813-17.
29. Zhang YJ, Jiang W, Chen CJ et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993; 196: 1010-16.
30. Sauter ER, Yeo UC, von Stemm A et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 2002; 62: 3200-6.
31. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther 2002; 1: 226-31.
32. Bastian BC. Understanding the progression of melanocytic neoplasia using genomic analysis: From fields to cancer. Oncogene 2003; 22: 3081-6.
33. Sviderskaya EV, Hill SP, Evans-Whipp TJ et al. p16 Ink4a in melanocyte senescence and differentiation. J Natl Cancer Inst 2002; 94: 446-54.
34. Ramirez RD, D'Atri S, Pagani E et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia 1999; 1: 42-9.